RVH-17569-14590
4 vaccinations
1 coded response
15 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 801 / CO
- Registered
- 2022-09-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-20
Dose 1 — Pfizer-BioNTech
-
2021-04-10
Dose 2 — Pfizer-BioNTech
-
2021-11-12
Dose 3 — Pfizer-BioNTech
-
2022-09-21
Registered in v-safe
-
2022-09-21
Dose 4 — Pfizer-BioNTech
- 2022-09-21
-
2022-09-22
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2022-09-23
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-11-02
- 2022-12-21
- 2023-03-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | No |
| 2 | 2021-04-10 | Pfizer-BioNTech | No |
| 3 | 2021-11-12 | Pfizer-BioNTech | No |
| 4 | 2022-09-21 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release